Click for best price
Cancer Infusion Therapy Market Size, Share 2022
Cancer treatments often require infusion treatments, like chemotherapy.?
This report contains market size and forecasts of Cancer Infusion Therapy in Global, including the following market information:
Global Cancer Infusion Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Infusion Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmacies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health and PharMerica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Infusion Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Infusion Therapy Market Segment Percentages, by Type, 2021 (%)
Pharmacies
Home Health Agencies
Others
Global Cancer Infusion Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Infusion Therapy Market Segment Percentages, by Application, 2021 (%)
Cancer
Chronic Disease
Others
Global Cancer Infusion Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Infusion Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Infusion Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Infusion Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
| Report Attributes |
Report Details |
| Report Title |
Cancer Infusion Therapy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Infusion Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Infusion Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Infusion Therapy Overall Market Size
2.1 Global Cancer Infusion Therapy Market Size: 2021 VS 2028
2.2 Global Cancer Infusion Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Infusion Therapy Players in Global Market
3.2 Top Global Cancer Infusion Therapy Companies Ranked by Revenue
3.3 Global Cancer Infusion Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Infusion Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Infusion Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Infusion Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Infusion Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Infusion Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Infusion Therapy Market Size Markets, 2021 & 2028
4.1.2 Pharmacies
4.1.3 Home Health Agencies
4.1.4 Others
4.2 By Type - Global Cancer Infusion Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Infusion Therapy Revenue, 2017-2022
4.2.2 By Type - Global Cancer Infusion Therapy Revenue, 2023-2028
4.2.3 By Type - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Infusion Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Chronic Disease
5.1.4 Others
5.2 By Application - Global Cancer Infusion Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Infusion Therapy Revenue, 2017-2022
5.2.2 By Application - Global Cancer Infusion Therapy Revenue, 2023-2028
5.2.3 By Application - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Infusion Therapy Market Size, 2021 & 2028
6.2 By Region - Global Cancer Infusion Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Infusion Therapy Revenue, 2017-2022
6.2.2 By Region - Global Cancer Infusion Therapy Revenue, 2023-2028
6.2.3 By Region - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Infusion Therapy Revenue, 2017-2028
6.3.2 US Cancer Infusion Therapy Market Size, 2017-2028
6.3.3 Canada Cancer Infusion Therapy Market Size, 2017-2028
6.3.4 Mexico Cancer Infusion Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Infusion Therapy Revenue, 2017-2028
6.4.2 Germany Cancer Infusion Therapy Market Size, 2017-2028
6.4.3 France Cancer Infusion Therapy Market Size, 2017-2028
6.4.4 U.K. Cancer Infusion Therapy Market Size, 2017-2028
6.4.5 Italy Cancer Infusion Therapy Market Size, 2017-2028
6.4.6 Russia Cancer Infusion Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Infusion Therapy Market Size, 2017-2028
6.4.8 Benelux Cancer Infusion Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Infusion Therapy Revenue, 2017-2028
6.5.2 China Cancer Infusion Therapy Market Size, 2017-2028
6.5.3 Japan Cancer Infusion Therapy Market Size, 2017-2028
6.5.4 South Korea Cancer Infusion Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Infusion Therapy Market Size, 2017-2028
6.5.6 India Cancer Infusion Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Infusion Therapy Revenue, 2017-2028
6.6.2 Brazil Cancer Infusion Therapy Market Size, 2017-2028
6.6.3 Argentina Cancer Infusion Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Infusion Therapy Revenue, 2017-2028
6.7.2 Turkey Cancer Infusion Therapy Market Size, 2017-2028
6.7.3 Israel Cancer Infusion Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Infusion Therapy Market Size, 2017-2028
6.7.5 UAE Cancer Infusion Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Option Care Health
7.1.1 Option Care Health Corporate Summary
7.1.2 Option Care Health Business Overview
7.1.3 Option Care Health Cancer Infusion Therapy Major Product Offerings
7.1.4 Option Care Health Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.1.5 Option Care Health Key News
7.2 Coram CVS
7.2.1 Coram CVS Corporate Summary
7.2.2 Coram CVS Business Overview
7.2.3 Coram CVS Cancer Infusion Therapy Major Product Offerings
7.2.4 Coram CVS Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.2.5 Coram CVS Key News
7.3 UnitedHealth Group
7.3.1 UnitedHealth Group Corporate Summary
7.3.2 UnitedHealth Group Business Overview
7.3.3 UnitedHealth Group Cancer Infusion Therapy Major Product Offerings
7.3.4 UnitedHealth Group Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.3.5 UnitedHealth Group Key News
7.4 HCA Healthcare
7.4.1 HCA Healthcare Corporate Summary
7.4.2 HCA Healthcare Business Overview
7.4.3 HCA Healthcare Cancer Infusion Therapy Major Product Offerings
7.4.4 HCA Healthcare Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.4.5 HCA Healthcare Key News
7.5 McLaren
7.5.1 McLaren Corporate Summary
7.5.2 McLaren Business Overview
7.5.3 McLaren Cancer Infusion Therapy Major Product Offerings
7.5.4 McLaren Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.5.5 McLaren Key News
7.6 CHI Health
7.6.1 CHI Health Corporate Summary
7.6.2 CHI Health Business Overview
7.6.3 CHI Health Cancer Infusion Therapy Major Product Offerings
7.6.4 CHI Health Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.6.5 CHI Health Key News
7.7 Accredo Health
7.7.1 Accredo Health Corporate Summary
7.7.2 Accredo Health Business Overview
7.7.3 Accredo Health Cancer Infusion Therapy Major Product Offerings
7.7.4 Accredo Health Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.7.5 Accredo Health Key News
7.8 PharMerica
7.8.1 PharMerica Corporate Summary
7.8.2 PharMerica Business Overview
7.8.3 PharMerica Cancer Infusion Therapy Major Product Offerings
7.8.4 PharMerica Cancer Infusion Therapy Revenue in Global Market (2017-2022)
7.8.5 PharMerica Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Infusion Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Infusion Therapy Market Drivers in Global Market
Table 3. Cancer Infusion Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Infusion Therapy in Global Market
Table 5. Top Cancer Infusion Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Infusion Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Infusion Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Infusion Therapy Product Type
Table 9. List of Global Tier 1 Cancer Infusion Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Infusion Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Infusion Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Infusion Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Option Care Health Corporate Summary
Table 31. Option Care Health Cancer Infusion Therapy Product Offerings
Table 32. Option Care Health Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Coram CVS Corporate Summary
Table 34. Coram CVS Cancer Infusion Therapy Product Offerings
Table 35. Coram CVS Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 36. UnitedHealth Group Corporate Summary
Table 37. UnitedHealth Group Cancer Infusion Therapy Product Offerings
Table 38. UnitedHealth Group Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 39. HCA Healthcare Corporate Summary
Table 40. HCA Healthcare Cancer Infusion Therapy Product Offerings
Table 41. HCA Healthcare Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 42. McLaren Corporate Summary
Table 43. McLaren Cancer Infusion Therapy Product Offerings
Table 44. McLaren Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CHI Health Corporate Summary
Table 46. CHI Health Cancer Infusion Therapy Product Offerings
Table 47. CHI Health Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Accredo Health Corporate Summary
Table 49. Accredo Health Cancer Infusion Therapy Product Offerings
Table 50. Accredo Health Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 51. PharMerica Corporate Summary
Table 52. PharMerica Cancer Infusion Therapy Product Offerings
Table 53. PharMerica Cancer Infusion Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Infusion Therapy Segment by Type in 2021
Figure 2. Cancer Infusion Therapy Segment by Application in 2021
Figure 3. Global Cancer Infusion Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Infusion Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Infusion Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Infusion Therapy Revenue in 2021
Figure 8. By Type - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 12. US Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 24. China Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Infusion Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Option Care Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Coram CVS Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UnitedHealth Group Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. HCA Healthcare Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. McLaren Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CHI Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Accredo Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. PharMerica Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
